Abstract
Occupational and environmental asbestos exposure is the main determinant of malignant pleural mesothelioma (MPM), however, the mechanisms by which its fibres contribute to cell toxicity and transformation are not completely clear. Aberrant DNA methylation is a common event in cancer but epigenetic modifications involved specifically in MPM carcinogenesis need to be better clarified. To investigate asbestos-induced DNA methylation and gene expression changes, we treated Met5A mesothelial cells with different concentrations of crocidolite and chrysotile asbestos (0.5 ÷ 5.0 µg/cm2, 72 h incubation). Overall, we observed 243 and 302 differentially methylated CpGs (≥ 10%) between the asbestos dose at 5 µg/cm2 and untreated control, in chrysotile and crocidolite treatment, respectively. To examine the dose–response effect, Spearman’s correlation test was performed and significant CpGs located in genes involved in migration/cell adhesion processes were identified in both treatments. Moreover, we found that both crocidolite and chrysotile exposure induced a significant up-regulation of CA9 and SRGN (log2 fold change > 1.5), previously reported as associated with a more aggressive MPM phenotype. However, we found no correlation between methylation and gene expression changes, except for a moderate significant inverse correlation at the promoter region of DKK1 (Spearman rho = − 1, P value = 0.02) after chrysotile exposure. These results describe for the first time the relationship between DNA methylation modifications and asbestos exposure. Our findings provide a basis to further explore and validate asbestos-induced DNA methylation changes, that could influence MPM carcinogenesis and possibly identifying new chemopreventive target.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Acencio MM, Soares B, Marchi E, Silva CS, Teixeira LR, Broaddus VC (2015) Inflammatory cytokines contribute to asbestos-induced injury of mesothelial cells. Lung 193:831–837. https://doi.org/10.1007/s00408-015-9744-4
Arsenic metals, fibres, and dusts (2012) IARC. Monogr Eval Carcinog Risks Hum 100:11–465
Bonotti A et al (2017) Serum mesothelin, osteopontin and vimentin: useful markers for clinical monitoring of malignant pleural mesothelioma. Int J Biol Markers 32:e126–e131. https://doi.org/10.5301/jbm.5000229
Boulanger G et al (2014) Quantification of short and long asbestos fibers to assess asbestos exposure: a review of fiber size toxicity. Environ Health 13:59. https://doi.org/10.1186/1476-069X-13-59
Burmeister B et al (2004) Effects of asbestos on initiation of DNA damage, induction of DNA-strand breaks, P53-expression and apoptosis in primary, SV40-transformed and malignant human mesothelial cells. Mutation research 558:81–92. https://doi.org/10.1016/j.mrgentox.2003.11.003
Bustin SA et al (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR. experiments Clin Chem 55:611–622. https://doi.org/10.1373/clinchem.2008.112797
Capkova L, Koubkova L, Kodet R (2014) Expression of carbonic anhydrase IX (CAIX) in malignant mesothelioma. An immunohistochemical immunocytochemical study. Neoplasma 61:161–169
Christensen BC et al (2008) Asbestos exposure predicts cell cycle control gene promoter methylation in pleural mesothelioma. Carcinogenesis 29:1555–1559. https://doi.org/10.1093/carcin/bgn059
Christensen BC et al (2009) Differentiation of lung adenocarcinoma, pleural mesothelioma, and nonmalignant pulmonary tissues using DNA methylation profiles. Cancer Res 69:6315–6321. https://doi.org/10.1158/0008-5472.CAN-09-1073
Daftuar L, Zhu Y, Jacq X, Prives C (2013) Ribosomal proteins RPL37, RPS15 and RPS20 regulate the Mdm2-p53-MdmX network. PLoS One 8:e68667. https://doi.org/10.1371/journal.pone.0068667
Dang CV, Semenza GL (1999) Oncogenic alterations of metabolism. Trends Biochem Sci 24:68–72
Das PM, Singal R (2004) DNA methylation and cancer. J Clin Oncol 22:4632–4642. https://doi.org/10.1200/JCO.2004.07.151
Fassina A, Cappellesso R, Guzzardo V, Dalla Via L, Piccolo S, Ventura L, Fassan M (2012) Epithelial–mesenchymal transition in malignant mesothelioma. Mod Pathol 25:86–99. https://doi.org/10.1038/modpathol.2011.144
Jain M, Bhat GP, Vijayraghavan K, Inamdar MS (2012) Rudhira/BCAS3 is a cytoskeletal protein that controls Cdc42 activation and directional cell migration during angiogenesis. Exp Cell Res 318:753–767. https://doi.org/10.1016/j.yexcr.2012.01.016
Kagan E (2013) Asbestos-induced mesothelioma: is fiber biopersistence really a critical factor? Am J Pathol 183:1378–1381. https://doi.org/10.1016/j.ajpath.2013.09.005
Kato T, Sato T, Yokoi K, Sekido Y (2017) E-cadherin expression is correlated with focal adhesion kinase inhibitor resistance in Merlin-negative malignant. mesothelioma cells Oncogene 36:5522–5531. https://doi.org/10.1038/onc.2017.147
Klier M, Jamali S, Ames S, Schneider HP, Becker HM, Deitmer JW (2016) Catalytic activity of human carbonic anhydrase isoform IX is displayed both extra- and intracellularly. Febs J 283:191–200. https://doi.org/10.1111/febs.13562
Lee AY et al (2004) Dickkopf-1 antagonizes Wnt signaling independent of beta-catenin in human mesothelioma. Biochem Biophys Res Commun 323:1246–1250. https://doi.org/10.1016/j.bbrc.2004.09.001
Li XJ et al (2011) Serglycin is a theranostic target in nasopharyngeal carcinoma that promotes metastasis. Cancer Res 71:3162–3172. https://doi.org/10.1158/0008-5472.CAN-10-3557
Li X, Wu Z, Wang Y, Mei Q, Fu X, Han W (2013) Characterization of adult alpha- and beta-globin elevated by hydrogen peroxide in cervical cancer cells that play a cytoprotective role against oxidative insults. PLoS One 8:e54342. https://doi.org/10.1371/journal.pone.0054342
Maeda M et al (2013) Alteration of cytoskeletal molecules in a human T cell line caused by continuous exposure to chrysotile asbestos. Immunobiology 218:1184–1191. https://doi.org/10.1016/j.imbio.2013.04.007
Maere S, Heymans K, Kuiper M (2005) BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics 21:3448–3449. https://doi.org/10.1093/bioinformatics/bti551
Melotti A, Daga A, Marubbi D, Zunino A, Mutti L, Corte G (2010) In vitro and in vivo characterization of highly purified human mesothelioma derived cells. BMC Cancer 10:54. https://doi.org/10.1186/1471-2407-10-54
Mirabelli D, Calisti R, Barone-Adesi F, Fornero E, Merletti F, Magnani C (2008) Excess of mesotheliomas after exposure to chrysotile in Balangero. Italy Occup Environ Med 65:815–819. https://doi.org/10.1136/oem.2007.037689
Mossman BT, Landesman JM (1983) Importance of oxygen free radicals in asbestos-induced injury to airway epithelial cells. Chest 83:50S–51S
Msiska Z, Pacurari M, Mishra A, Leonard SS, Castranova V, Vallyathan V (2010) DNA double-strand breaks by asbestos, silica, and titanium dioxide: possible biomarker of carcinogenic potential? Am J Respir Cell Mol Biol 43:210–219. https://doi.org/10.1165/rcmb.2009-0062OC
Nabavi N, Bennewith KL, Churg A, Wang Y, Collins CC, Mutti L (2016) Switching off malignant mesothelioma: exploiting the hypoxic microenvironment. Genes Cancer 7:340–354. https://doi.org/10.18632/genesandcancer.124
Nymark P et al (2007) Gene expression profiles in asbestos-exposed epithelial and mesothelial lung cell lines. BMC Genom 8:62. https://doi.org/10.1186/1471-2164-8-62
Patard JJ et al (2008) Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinoma. Int J Cancer 123:395–400. https://doi.org/10.1002/ijc.23496
Pietruska JR, Johnston T, Zhitkovich A, Kane AB (2010) XRCC1 deficiency sensitizes human lung epithelial cells to genotoxicity by crocidolite asbestos and Libby amphibole. Environ Health Perspect 118:1707–1713. https://doi.org/10.1289/ehp.1002312
Pistolesi M, Rusthoven J (2004) Malignant pleural mesothelioma: update, current management and newer therapeutic strategies. Chest 126:1318–1329. https://doi.org/10.1378/chest.126.4.1318
Ramsey ML, Yuh BJ, Johnson MT, Yeldandi AV, Zynger DL (2012) Carbonic anhydrase IX is expressed in mesothelioma and metastatic clear cell renal cell carcinoma of the lung. Virchows Arch 460:89–93. https://doi.org/10.1007/s00428-011-1178-7
Rijlaarsdam MA, van der Zwan YG, Dorssers LC, Looijenga LH (2014) DMRforPairs: identifying differentially methylated regions between unique samples using array based methylation profiles. BMC Bioinf 15:141. https://doi.org/10.1186/1471-2105-15-141
Sekido Y (2008) Molecular biology of malignant mesothelioma Environ. Health Prev Med 13:65–70. https://doi.org/10.1007/s12199-007-0015-8
Sen D (2015) Working with asbestos and the possible health risks. Occup Med (Lond) 65:6–14. https://doi.org/10.1093/occmed/kqu175
Shukla A et al (2009) Alterations in gene expression in human mesothelial cells correlate with mineral pathogenicity. Am J Respir Cell Mol Biol 41:114–123. https://doi.org/10.1165/rcmb.2008-0146OC
Singhal S et al (2003) Gene expression profiling of malignant mesothelioma. Clin Cancer Res 9:3080–3097
Skliris A, Labropoulou VT, Papachristou DJ, Aletras A, Karamanos NK, Theocharis AD (2013) Cell-surface serglycin promotes adhesion of myeloma cells to collagen type I and affects the expression of matrix metalloproteinases. Febs J 280:2342–2352. https://doi.org/10.1111/febs.12179
Tomasetti M, Amati M, Neuzil J, Santarelli L (2017) Circulating epigenetic biomarkers in lung malignancies: From early diagnosis to therapy. Lung Cancer 107:65–72. https://doi.org/10.1016/j.lungcan.2016.05.023
Treadwell MD, Mossman BT, Barchowsky A (1996) Increased neutrophil adherence to endothelial cells exposed to asbestos. Toxicol Appl Pharmacol 139:62–70. https://doi.org/10.1006/taap.1996.0143
Trevisan E et al (2016) Histopathological data of iron and calcium in the mouse lung after asbestos exposure. Data Brief 6:769–775. https://doi.org/10.1016/j.dib.2016.01.026
Tweedale G (2002) Asbestos and its lethal legacy. Nat Rev Cancer 2:311–315. https://doi.org/10.1038/nrc774
Tyan SW et al (2012) Breast cancer cells induce stromal fibroblasts to secrete ADAMTS1 for cancer invasion through an epigenetic change. PLoS One 7:e35128. https://doi.org/10.1371/journal.pone.0035128
Urso L, Calabrese F, Favaretto A, Conte P, Pasello G (2016) Critical review about MDM2 in cancer: possible role in malignant mesothelioma and implications for treatment. Crit Rev Oncol Hematol 97:220–230. https://doi.org/10.1016/j.critrevonc.2015.08.019
Vandermeers F, Neelature Sriramareddy S, Costa C, Hubaux R, Cosse JP, Willems L (2013) The role of epigenetics in malignant pleural mesothelioma. Lung Cancer 81:311–318. https://doi.org/10.1016/j.lungcan.2013.05.014
Vaslet CA, Messier NJ, Kane AB (2002) Accelerated progression of asbestos-induced mesotheliomas in heterozygous p53+/− mice. Toxicol Sci 68:331–338
Wang H et al (2011) Crocidolite asbestos-induced signal pathway dysregulation in mesothelial cells. Mutat Res 723:171–176. https://doi.org/10.1016/j.mrgentox.2011.04.008
Acknowledgements
The authors would like to thank Prof. Corrado Magnani for scientific revision of the manuscript. This work was supported by AIRC “Associazione Italiana per la Ricerca sul Cancro” (project AIRC 2015 IG 17464, G.M.); the Italian Institute for genomic Medicine (IIGM) and Compagnia di San Paolo Torino, Italy (G.M.) and by Fondazione Umberto Veronesi “Post-doctoral fellowship Year 2014, 2015 and 2016” (B.P. recipient).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Casalone, E., Allione, A., Viberti, C. et al. DNA methylation profiling of asbestos-treated MeT5A cell line reveals novel pathways implicated in asbestos response. Arch Toxicol 92, 1785–1795 (2018). https://doi.org/10.1007/s00204-018-2179-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00204-018-2179-y